JP2023533679A5 - - Google Patents
Info
- Publication number
- JP2023533679A5 JP2023533679A5 JP2022579760A JP2022579760A JP2023533679A5 JP 2023533679 A5 JP2023533679 A5 JP 2023533679A5 JP 2022579760 A JP2022579760 A JP 2022579760A JP 2022579760 A JP2022579760 A JP 2022579760A JP 2023533679 A5 JP2023533679 A5 JP 2023533679A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- delivery system
- drug delivery
- linkage
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/102115 | 2020-07-15 | ||
| CN2020102115 | 2020-07-15 | ||
| PCT/CN2021/105899 WO2022012492A1 (en) | 2020-07-15 | 2021-07-13 | Drug delivery system for locally delivering therapeutic agents and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023533679A JP2023533679A (ja) | 2023-08-04 |
| JP2023533679A5 true JP2023533679A5 (https=) | 2024-07-12 |
Family
ID=79555042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579760A Pending JP2023533679A (ja) | 2020-07-15 | 2021-07-13 | 治療剤を局所的に送達するための薬物送達システムおよびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230256106A1 (https=) |
| EP (1) | EP4181963A4 (https=) |
| JP (1) | JP2023533679A (https=) |
| KR (1) | KR20230040957A (https=) |
| CN (2) | CN115867319B (https=) |
| AU (1) | AU2021310171A1 (https=) |
| BR (1) | BR112022021179A2 (https=) |
| CA (1) | CA3179897A1 (https=) |
| IL (1) | IL297377A (https=) |
| WO (1) | WO2022012492A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114907353A (zh) * | 2021-02-09 | 2022-08-16 | 明慧医药（杭州）有限公司 | 一种前药化合物及其制备方法和用途 |
| CN117355527B (zh) * | 2021-07-20 | 2024-06-07 | 上海椿安生物医药科技有限公司 | 一种消炎偶联化合物药物及其制法和应用 |
| JP2025505812A (ja) * | 2022-02-21 | 2025-02-28 | オンクオリティ ファーマシューティカルズ チャイナ リミテッド | 化合物及びその用途 |
| KR20250012423A (ko) * | 2023-07-17 | 2025-01-24 | 차의과학대학교 산학협력단 | 금 나노입자 및 상환변환 나노입자로부터 형성된 일시적 광천공을 위한 나노복합체 |
| WO2026002095A1 (en) * | 2024-06-26 | 2026-01-02 | Coval Biopharma (Shanghai) Co., Ltd. | Drug delivery system for locally controlled release of therapeutic agents and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITPD20020271A1 (it) * | 2002-10-18 | 2004-04-19 | Fidia Farmaceutici | Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati. |
| EP1710257A4 (en) * | 2004-01-07 | 2011-03-23 | Seikagaku Kogyo Co Ltd | HYALURONIC ACID DERIVATIVE AND MEDICAMENT CONTAINING THEREOF |
| CA2609069A1 (en) * | 2005-05-18 | 2006-11-23 | Eurand Pharmaceuticals Limited | Antiproliferative conjugates comprising hyaluronic acid and n-derivatives of glutamic acid |
| IE20060049A1 (en) * | 2006-01-25 | 2007-08-08 | Eurand Pharmaceuticals Ltd | A novel drug delivery system: use of hyaluronic acid as a carrier moleclue for different classes of therapeutic active agents |
| IE20060565A1 (en) * | 2006-07-28 | 2008-02-06 | Eurand Pharmaceuticals Ltd | Drug delivery system based on regioselectively amidated hyaluronic acid |
| IE20070900A1 (en) * | 2007-12-12 | 2009-06-24 | Eurand Pharmaceuticals Ltd | New anticancer conjugates |
| BRPI0910570A2 (pt) * | 2008-04-22 | 2015-09-22 | Fidia Farmaceutici | uso de bioconjugados, e, formulações farmacêuticas |
| CN101745119B (zh) * | 2010-01-25 | 2012-07-25 | 中国药科大学 | 羧酸类药物-多糖偶联物及其制备方法与应用 |
| BR112014032916A2 (pt) * | 2012-06-28 | 2017-08-01 | Pfizer | anticorpos anti-fármacos e usos destes para o monitoramento de fármaco |
| WO2014038641A1 (ja) * | 2012-09-05 | 2014-03-13 | 中外製薬株式会社 | アミノ酸およびステリル基が導入されたヒアルロン酸誘導体 |
| KR101467076B1 (ko) * | 2013-02-20 | 2014-12-02 | 성균관대학교산학협력단 | 히알루론산-메토트렉세이트 접합체를 포함하는 관절염 예방 또는 치료용 약학적 조성물 및 이의 제조방법 |
| CN103751795B (zh) * | 2013-05-20 | 2017-02-08 | 中国药科大学 | 透明质酸‑抗肿瘤药偶联物及复合纳米粒组合物的制备和应用 |
| WO2015005458A1 (ja) * | 2013-07-10 | 2015-01-15 | 生化学工業株式会社 | グリコサミノグリカン誘導体及びその製造方法 |
| US9572832B2 (en) * | 2013-08-29 | 2017-02-21 | Holy Stone Healthcare Co., Ltd. | Compound of glycosaminoglycan and its fabrication method as well as application |
| CN104491875A (zh) * | 2014-12-22 | 2015-04-08 | 中国药科大学 | 一种基于透明质酸-难溶性药物前药的自聚纳米系统的制备方法 |
| CN107096036B (zh) * | 2017-04-12 | 2020-01-14 | 武汉理工大学 | 一种pH敏感型透明质酸-多柔比星纳米前药的制备方法及其应用 |
| JOP20190245A1 (ar) * | 2017-04-20 | 2019-10-15 | Novartis Ag | أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط |
| CN108467439A (zh) * | 2018-03-22 | 2018-08-31 | 盐城师范学院 | 一种水溶性紫杉醇抗癌药物的制备方法 |
| SG11202105128RA (en) * | 2018-12-12 | 2021-06-29 | Agency Science Tech & Res | Conjugates and nanoparticles of hyaluronic acid and epigallocatechin-3-o-gallate and uses thereof |
| CA3181304A1 (en) * | 2020-06-05 | 2021-12-09 | Abdel-Rahman Lawendy | Cannabinoid-hyaluronic acid bioconjugates |
-
2021
- 2021-07-13 CA CA3179897A patent/CA3179897A1/en active Pending
- 2021-07-13 KR KR1020227045471A patent/KR20230040957A/ko active Pending
- 2021-07-13 IL IL297377A patent/IL297377A/en unknown
- 2021-07-13 AU AU2021310171A patent/AU2021310171A1/en active Pending
- 2021-07-13 BR BR112022021179A patent/BR112022021179A2/pt unknown
- 2021-07-13 EP EP21841888.7A patent/EP4181963A4/en active Pending
- 2021-07-13 JP JP2022579760A patent/JP2023533679A/ja active Pending
- 2021-07-13 US US18/005,356 patent/US20230256106A1/en active Pending
- 2021-07-13 CN CN202180049488.5A patent/CN115867319B/zh active Active
- 2021-07-13 CN CN202311685488.1A patent/CN117838875B/zh active Active
- 2021-07-13 WO PCT/CN2021/105899 patent/WO2022012492A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023533679A5 (https=) | ||
| JP6661744B2 (ja) | ＨＰＴＰ−β阻害剤 | |
| JP2019504100A5 (https=) | ||
| JP2016516068A5 (https=) | ||
| JP2018520352A (ja) | アルギナーゼ活性を阻害するための組成物および方法 | |
| JP2022516945A5 (https=) | ||
| TWI710555B (zh) | 新穎水溶性前藥 | |
| RU2015129062A (ru) | Соединения 3, 5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида | |
| JP2023544716A5 (https=) | ||
| ES2579942T3 (es) | Pirazolilaminoquinazolina ópticamente activa y composiciones farmacéuticas y métodos de uso de la misma | |
| JP2021503449A5 (https=) | ||
| JP2002537251A (ja) | 血管形成を伴う疾患の治療に対する併用 | |
| CA3106568A1 (en) | Therapeutic dendrimer | |
| JP2007529426A5 (https=) | ||
| TW202133882A (zh) | 肽與多醣的新共軛物 | |
| KR102266014B1 (ko) | 안질환 예방 또는 치료용 점안 조성물 | |
| JP2021505550A5 (https=) | ||
| CA3166379A1 (en) | Inhibitors of glutathione s-transferases (gsts) and nad(p)h:quinone oxidoreductase 1 (nqo1), pharmaceutical compositions, and uses in managing cancer | |
| JP2021138710A5 (https=) | ||
| BR112019025478A2 (pt) | Combinação de regorafenib e inibidores de pd-1/pd-l1(2) para tratamento de câncer | |
| CN107001617B (zh) | Peg衍生物 | |
| US20200054580A1 (en) | Methods of treating a neurological or psychiatric disorder | |
| KR20120081585A (ko) | 안질환을 치료하기 위한 이소티오졸 | |
| US20160143914A1 (en) | Nanoparticles for Encapsulation and Delivery of Bioactive Compounds and Compositions Thereof | |
| US20250170143A1 (en) | Methods of treating ocular fibrotic pathologies |